Simplex Trading’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.1M | Buy |
1,315,300
+881,300
| +203% | +$6.03M | 0.01% | 696 |
|
|
2025
Q4 | $859K | Sell |
434,000
-186,300
| -30% | -$422K | ﹤0.01% | 2778 |
|
|
2025
Q3 | $1.52M | Buy |
620,300
+110,100
| +22% | +$284K | ﹤0.01% | 2596 |
|
|
2025
Q2 | $1.35M | Buy |
510,200
+109,100
| +27% | +$293K | ﹤0.01% | 2478 |
|
|
2025
Q1 | $1.21M | Sell |
401,100
-240,800
| -38% | -$730K | ﹤0.01% | 2520 |
|
|
2024
Q4 | $1.64M | Buy |
641,900
+18,800
| +3% | +$78.3K | ﹤0.01% | 2370 |
|
|
2024
Q3 | $2.32M | Buy |
623,100
+168,800
| +37% | +$781K | ﹤0.01% | 2156 |
|
|
2024
Q2 | $2.87M | Sell |
454,300
-132,500
| -23% | -$874K | ﹤0.01% | 1876 |
|
|
2024
Q1 | $3.15M | Buy |
586,800
+333,300
| +131% | +$1.51M | ﹤0.01% | 1984 |
|
|
2023
Q4 | $1.27M | Buy |
253,500
+56,900
| +29% | +$179K | ﹤0.01% | 2786 |
|
|
2023
Q3 | $332K | Sell |
196,600
-22,500
| -10% | -$45.2K | ﹤0.01% | 3834 |
|
|
2023
Q2 | $609K | Buy |
219,100
+163,100
| +291% | +$461K | ﹤0.01% | 3102 |
|
|
2023
Q1 | $101K | Buy |
56,000
+600
| +1% | +$1.87K | ﹤0.01% | 5142 |
|
|
2022
Q4 | $280K | Sell |
55,400
-9,700
| -15% | -$53.3K | ﹤0.01% | 3823 |
|
|
2022
Q3 | $323K | Sell |
65,100
-58,000
| -47% | -$264K | ﹤0.01% | 3990 |
|
|
2022
Q2 | $457K | Sell |
123,100
-12,600
| -9% | -$50.6K | ﹤0.01% | 3544 |
|
|
2022
Q1 | $761K | Buy |
135,700
+45,300
| +50% | +$278K | ﹤0.01% | 3272 |
|
|
2021
Q4 | $549K | Buy |
90,400
+64,700
| +252% | +$486K | ﹤0.01% | 3663 |
|
|
2021
Q3 | $365K | Buy |
25,700
+200
| +0.8% | +$2.2K | ﹤0.01% | 4581 |
|
|
2021
Q2 | $364K | Buy |
25,500
+25,189
| +8,099% | +$416K | ﹤0.01% | 4652 |
|
|
2021
Q1 | $738K | Buy |
311
+170
| +121% | +$4.41K | ﹤0.01% | 2814 |
|
|
2020
Q4 | $187K | Sell |
141
-147
| -51% | -$1.41K | ﹤0.01% | 4697 |
|
|
2020
Q3 | $199K | Sell |
288
-6
| -2% | -$60 | ﹤0.01% | 4111 |
|
|
2020
Q2 | $361K | Buy |
294
+287
| +4,100% | +$1.62K | ﹤0.01% | 3295 |
|
|
2020
Q1 | $2K | Sell |
7
-97
| -93% | -$486 | ﹤0.01% | 7194 |
|
|
2019
Q4 | $39K | Sell |
104
-5
| -5% | -$9 | ﹤0.01% | 5423 |
|
|
2019
Q3 | $13K | Buy |
+109
| New | +$135 | ﹤0.01% | 6091 |
|
|
2017
Q4 | – | Sell |
-87
| Closed | -$13K | – | 6276 |
|
|
2017
Q3 | $13K | Sell |
87
-317
| -78% | -$1.95K | ﹤0.01% | 3544 |
|
|
2017
Q2 | $108K | Buy |
+404
| New | +$1.75K | ﹤0.01% | 1690 |
|
|
2017
Q1 | – | Sell |
-45
| Closed | -$1K | – | 6416 |
|
|
2016
Q4 | $1K | Sell |
45
-30
| -40% | -$200 | ﹤0.01% | 5408 |
|
|
2016
Q3 | $10K | Sell |
75
-251
| -77% | -$1.88K | ﹤0.01% | 3617 |
|
|
2016
Q2 | $4K | Buy |
326
+303
| +1,317% | +$2.35K | ﹤0.01% | 4430 |
|
|
2016
Q1 | $2K | Sell |
23
-14
| -38% | -$132 | ﹤0.01% | 4723 |
|
|
2015
Q4 | $3K | Buy |
+37
| New | +$549 | ﹤0.01% | 4232 |
|
Other funds holding IBRX
VPM
VCM
HF
WP
Simplex Trading's IBRX Position: Q1 2026 in Review
Simplex Trading sold out of ImmunityBio (IBRX) in Q1 2026, closing a stake of 493,445 shares — an estimated $3.38M sold.
Simplex Trading first reported a position in IBRX in Q3 2015 and held it in 28 quarters. The position peaked at $977K in Q4 2025. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.
- Simplex Trading reported no remaining ImmunityBio position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 493,445 ImmunityBio shares in Q1 2026, an estimated $3.38M.
- Simplex Trading first reported a position in ImmunityBio in Q3 2015 and held it in 28 quarters.
- Simplex Trading's ImmunityBio position peaked at $977K in Q4 2025.
- 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.